美股市場個股詳情
GERNW GERON CORP C/WTS 31/12/2025 (TO SUB FOR ORD)
- 1.400
- 0.0000.00%
延時15分鐘行情收盤價 12/26 16:00 (美東)
0總市值0.00市盈率TTM
0.000最高價0.000最低價0股成交量0.000今開1.400昨收0.00成交額0.00%換手率0.00市盈率(靜)0總股本2.14052周最高0.00市淨率0流通值0.72552周最低--股息TTM0流通股2.140歷史最高--股息率TTM0.00%振幅0.725歷史最低--平均價1股每手
關於GERON CORP C/WTS 31/12/2025 (TO SUB FOR ORD)公司
傑龍公司是一家臨牀階段生物製藥公司，專注於研究和開發癌症治療藥物。公司的在研藥物 Imelstat 正在接受測試，用於治療骨髓增生異常綜合徵，一種血液疾病，和骨髓纖維化，一種影響骨髓的罕見血癌。公司通過合作協議，里程碑，版稅和許可安排獲得收入。傑龍擁有該藥物的各種權利。該公司的業務只有一個分部，即開發腫瘤治療產品。
公司介紹
公司代碼GERNW
公司名稱GERON CORP C/WTS 31/12/2025 (TO SUB FOR ORD)
上市日期1996/07/30
成立日期1990
CEODr. John A. Scarlett,M.D.
所屬市場粉單
員工數量141
年結日12-31
公司地址919 East Hillsdale Boulevard,Suite 250
城市Foster City
省份加利福尼亞州
國家美國
郵編94404
電話1-650-473-7700
董事高管
- 姓名
- 職務
- 年薪
- Dr. John A. Scarlett,M.D.
- Chairman of the Board, Chief Executive Officer and President
- 492.41萬
- Melissa A. Kelly Behrs
- Executive Vice President, Business Operations and Chief Alliance Officer
- --
- Shannon T. Odam
- Senior Vice President and Chief People Officer
- --
- Anil Kapur
- Executive Vice President, Corporate Strategy and Chief Commercial Officer
- --
- Dr. Andrew J. Grethlein,PhD
- Executive Vice President and Chief Operating Officer
- 241.51萬
- Scott A. Samuels
- Executive Vice President, Chief Legal Officer and Corporate Secretary
- 360.87萬
- Dr. Faye Feller
- Executive Vice President and Chief Medical Officer
- --
- Michelle Robertson
- Executive Vice President, Finance, Chief Financial Officer, Principal Accounting Officer and Treasurer
- 246.97萬
- Edward E. Koval
- Executive Vice President and Chief Business Officer
- --
- Elizabeth G. O’Farrell
- Lead Independent Director
- 37.55萬
- Dr. Gaurav Aggarwal, M.D.
- Independent Director
- 29.08萬
- Dawn Carter Bir
- Independent Director
- 34.31萬
- Dr. Robert J. Spiegel, F.A.C.P.,M.D.
- Independent Director
- 35.09萬
- Dr. V. Bryan Lawlis, PhD
- Independent Director
- 36.09萬
- Dr. Susan M. Molineaux, PhD
- Independent Director
- 34.59萬
- John F. McDonald
- Independent Director
- 34.84萬
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據